Integrating diabetic retinopathy screening within diabetes education services in Australia's diabetes and indigenous primary care clinics.


Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
06 2019
Historique:
received: 20 09 2018
revised: 19 11 2018
accepted: 20 11 2018
entrez: 12 6 2019
pubmed: 12 6 2019
medline: 14 2 2020
Statut: ppublish

Résumé

As diabetes occurs in all ethnicities and regions it is essential that retinopathy screening be widely available. Screening rates are lower in Indigenous than in non-Indigenous Australians. Technological advances and Medicare rebates should facilitate improved outcomes. Use of non-ophthalmic clinicians, (general practitioners, diabetes educators, health-workers and endocrinologists) to supplement coverage by ophthalmologists and optometrists would extend retinopathy screening capacity. Diabetes educators are an integral part of diabetes management. Integrating ocular screening and diabetes education in primary care settings has potential to improve synergistically retinopathy screening coverage, patient self-management, risk factor control, care satisfaction, health economics and sustainability of under-resourced services.

Identifiants

pubmed: 31185524
doi: 10.1111/imj.14309
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

797-800

Subventions

Organisme : NHMRC CRE in Diabetic Retinopathy
Pays : International
Organisme : NHMRC Practitioner Fellowship
Pays : International
Organisme : Sydney Medical School Foundation
Pays : International
Organisme : POCHE
Pays : International
Organisme : NHMRC Clinical Trials Centre
Pays : International

Informations de copyright

© 2019 Royal Australasian College of Physicians.

Auteurs

Sharon Atkinson-Briggs (S)

Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.

Alicia Jenkins (A)

Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.

Anthony Keech (A)

Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.

Christopher Ryan (C)

Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.

Laima Brazionis (L)

Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH